| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.00B | -9.7% | +12.4% |
| Cost of Revenue | $4.22B | — | +5.4% |
| R&D Expense | $2.47B | — | +19.6% |
| SG&A Expense | $3.58B | — | +8.7% |
| Operating Income | $3.99B | — | +6.9% |
| Interest Expense | $717.0M | — | +2.4% |
| Pre-tax Income | $1.04B | — | -37.4% |
| Income Tax | $342.0M | — | -8.1% |
| Net Income | $695.0M | -61.7% | -46.0% |
| EPS (Basic) | $0.39 | -61.8% | -45.8% |
| EPS (Diluted) | $0.39 | -61.8% | -45.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.39B | +79.6% | +81.5% |
| Accounts Receivable | $12.48B | -0.9% | +0.0% |
| Inventory | $5.05B | +2.0% | +11.6% |
| Current Assets | $33.53B | +15.4% | +21.2% |
| Total Assets | $136.46B | +1.9% | +0.2% |
| Current Liabilities | $42.10B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.83B | — | +134.2% |
| Capital Expenditures | $265.0M | — | +12.8% |
| Investing Cash Flow | -$574.0M | — | +21.9% |
| Financing Cash Flow | $919.0M | — | +173.1% |
| Free Cash Flow | $3.56B | — | +154.6% |
| +15.6% |
| Long-term Debt | $64.53B | +0.0% | +0.0% |
| Stockholders' Equity | -$6.66B | -103.5% | -568.7% |